What does it take to make progress in a disease?
Ringel, M. S.; Dethier, J.; Davitt, M. J.; Denslow, M.; Fowler, R. A.; Hasenfuss, S. C.; Schulze, U.
Show abstract
In this paper, we investigate what conditions need to be in place to make progress in combating a disease using a case-control design: we compare cases (diseases with a successful therapy) to controls (diseases without a successful therapy). We find five conditions ("hurdles") must typically be cleared for success: (A) understanding of biological drivers, (B) ability to modulate biology, (C) availability of translational models, (D1) ability to identify patients, and (D2) ability to measure clinical response. This framework is similar to ones deployed to evaluate individual drug candidates but is employed here to make inferences about entire diseases. It can be used to identify diseases most ready for progress, where efforts should be focused to make progress in diseases that are currently intractable, and where the industry could benefit from development of tools to address the hurdle that is most commonly the last to be cleared across diseases--namely, (C) translational models.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response Outcomes 89%
- In silico PK predictions in Drug Discovery: Benchmarking of Strategies to Integrate Machine Learning with Empiric and Mechanistic PK modelling 89%
- An untargeted metabolomics analysis of exogenous chemicals in human milk and transfer to the infant 88%
Similar papers in this journal
- DrugWAS: Leveraging drug-wide association studies to facilitate drug repurposing for COVID-19 91%
- Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics 89%
- Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition 88%
Similar papers in this journal
- Experimental control of macrophage pro-inflammatory dynamics using predictive models 87%
- Leveraging microfluidic dielectrophoresis to distinguish compositional variations of lipopolysaccharide in E. coli 86%
- Localized delivery of β-NGF via injectable microrods accelerates endochondral fracture repair 85%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.